Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Effects of Nebulized Epoprostenol (Flolan) and Systemic Phenylephrine on Arterial Oxygenation During One Lung Ventilation

NCT02748265 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT02748265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02748265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Effects of Nebulized Epoprostenol (Flolan) and Systemic Phenylephrine on Arterial Oxygenation During One Lung Ventilation
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2016
Completion date
December 31, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxygenation during one lung ventilation